0

539470

SHREEGANES

img img img img
No Data Available

Shree Ganesh Biotech (India) L Share Price Update

As of the latest trading session, Shree Ganesh Biotech (India) L is trading at ₹0.61, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹0.60 and ₹0.62 today. Over the past year, the stock has delivered a return of -31.46%. In the last month, it has returned 12.96%.

Investment Returns

Over 1 Month 12.96% Over 3 Months -3.17% Over 6 Months -17.56% Over 1 Year -31.46%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Shree Ganesh Biotech (India) L fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 24.30
  • P/E Ratio (TTM) -61.00
  • Beta 0.57
  • Book Value / share 1.59
  • Return on equity 0.44%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.32
info icon alternate text

Shree Ganesh Biotech (India) L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 0.70
Operating Expense 0.75
Net Profit 0.32
Net Profit Margin (%) 45.71
Earnings Per Share (EPS) 0.01
EBITDA 0.32
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.77
Operating Expense 1.16
Net Profit 0.01
Net Profit Margin (%) 1.29
Earnings Per Share (EPS) 0.00
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.38
Operating Expense 1.47
Net Profit 0.33
Net Profit Margin (%) 23.91
Earnings Per Share (EPS) 0.01
EBITDA 0.33
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 3.01
Operating Expense 4.42
Net Profit -0.95
Net Profit Margin (%) -31.56
Earnings Per Share (EPS) -0.02
EBITDA -0.95
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 14.41
Operating Expense 13.94
Net Profit 0.77
Net Profit Margin (%) 5.34
Earnings Per Share (EPS) 0.02
EBITDA 0.77
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 22.96
Operating Expense 24.01
Net Profit 0.28
Net Profit Margin (%) 1.21
Earnings Per Share (EPS) 0.01
EBITDA 0.39
Effective Tax Rate (%) 28.20
Particulars MAR 2024 (Values in Cr)
Revenue 20.28
Operating Expense 20.48
Net Profit 0.62
Net Profit Margin (%) 3.05
Earnings Per Share (EPS) 0.02
EBITDA 0.85
Effective Tax Rate (%) 27.05
Particulars MAR 2023 (Values in Cr)
Revenue 62.45
Operating Expense 60.31
Net Profit 2.04
Net Profit Margin (%) 3.26
Earnings Per Share (EPS) 0.05
EBITDA 2.71
Effective Tax Rate (%) 25.09
Particulars MAR 2022 (Values in Cr)
Revenue 72.64
Operating Expense 69.20
Net Profit 2.53
Net Profit Margin (%) 3.48
Earnings Per Share (EPS) 0.13
EBITDA 3.50
Effective Tax Rate (%) 27.71
Particulars MAR 2021 (Values in Cr)
Revenue 17.21
Operating Expense 16.51
Net Profit 0.32
Net Profit Margin (%) 1.85
Earnings Per Share (EPS) 0.02
EBITDA 0.43
Effective Tax Rate (%) 25.58
Particulars MAR 2025 (Values in Cr)
Book Value / Share 1.59
ROE % 0.44
ROCE % 0.62
Total Debt to Total Equity 0.00
EBITDA Margin 1.70
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.58
ROE % 0.99
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 4.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.56
ROE % 3.33
ROCE % 4.43
Total Debt to Total Equity 0.00
EBITDA Margin 4.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.03
ROE % 4.28
ROCE % 5.92
Total Debt to Total Equity 0.00
EBITDA Margin 4.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.00
ROE % 0.92
ROCE % 1.23
Total Debt to Total Equity 0.00
EBITDA Margin 4.13
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 63.48
Total Liabilities 63.48
Total Equity 63.25
Share Outstanding 39
Price to Book Ratio 0.57
Return on Assets (%) 0.43
Return on Capital (%) 0.44
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 73.62
Total Liabilities 73.62
Total Equity 62.97
Share Outstanding 39
Price to Book Ratio 0.66
Return on Assets (%) 0.84
Return on Capital (%) 0.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.48
Total Assets 79.52
Total Liabilities 79.52
Total Equity 62.35
Share Outstanding 39
Price to Book Ratio 0.65
Return on Assets (%) 2.56
Return on Capital (%) 3.27
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 93.55
Total Liabilities 93.55
Total Equity 60.31
Share Outstanding 19
Price to Book Ratio 3.07
Return on Assets (%) 2.69
Return on Capital (%) 4.19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 74.62
Total Liabilities 74.62
Total Equity 57.79
Share Outstanding 1
Price to Book Ratio 4.09
Return on Assets (%) 0.42
Return on Capital (%) 0.55
Particulars MAR 2025 (Values in Cr)
Net Income 0.38
Cash from Operations -10.21
Cash from Investing 9.79
Cash from Financing 0.00
Net change in Cash -0.41
Free Cash Flow -10.21
Particulars MAR 2024 (Values in Cr)
Net Income 0.85
Cash from Operations 10.15
Cash from Investing -10.20
Cash from Financing 0.00
Net change in Cash -0.05
Free Cash Flow 10.15
Particulars MAR 2023 (Values in Cr)
Net Income 2.71
Cash from Operations 11.21
Cash from Investing -10.09
Cash from Financing 0.00
Net change in Cash 0.44
Free Cash Flow 11.21
Particulars MAR 2022 (Values in Cr)
Net Income 3.49
Cash from Operations 4.54
Cash from Investing -3.36
Cash from Financing -0.19
Net change in Cash 0.01
Free Cash Flow 4.54
Particulars MAR 2021 (Values in Cr)
Net Income 0.42
Cash from Operations 2.47
Cash from Investing -2.35
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 2.47
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.77 1.65 243.69 23.12 40.44
BLISS GVS PHARMA LTD. 276.25 26.41 2.58 2922.42 105.05 280.20
CIPLA LTD 1309.90 22.25 3.21 105811.45 1165.55 1672.20
FERMENTA BIOTECH LTD. 311.40 10.36 2.34 916.48 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2335.60 39.34 23.16 39566.47 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 30.58 4.43 243.69 23.12 40.44
AMRUTAJAN HEALTH LTD 570.45 28.52 4.82 1649.21 490.00 789.95
ASTRAZENECA PHARMA IND LT 8217.20 98.75 25.71 20543.00 7630.00 10653.05
BLISS GVS PHARMA LTD. 276.25 37.64 2.64 2922.42 105.05 280.20

Shree Ganesh Biotech (India) L shareholding pattern

Holding
98.57%
1.42%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)

Shree Ganesh Biotech (India) L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
0.61 0.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 0.60
  • 26 Days 0.60
  • 10 Days 0.60
  • 50 Days 0.60
  • 12 Days 0.60
  • 100 Days 0.60
  • 20 Days 0.60
  • 200 Days 0.70
0.61 PIVOT
First Support 0.60 First Resistance 0.63 Second Support 0.58 Second Resistance 0.64 Third Support 0.57 Third Resistance 0.66
RSI 43.55 ADX 36.24 MACD 0.00 Williams % R -81.82 Commodity Channel Index (CCI) -82.83
Date 2026-04-30 Week 562216.00 Same Day 265497.00 Month 562660.00
1 Year 0.57 3 Year 0.51
Over 1 Month
12.96% down
Over 1 Year
-31.46% down
Over 3 Months
-3.17% down
Over 3 Years
-18.57% down
Over 6 Months
-17.56% down
Over 5 Years
-36.30% down

Shree Ganesh Biotech (India) L Corporate Actions

Ex-Date Ex-Bonus Ratio
28 Apr 2022 27 Apr 2022 1:1
Ex-Date Old FV NEW FV Record Date
10 Feb 2022 10.0 1.0 11 Feb 2022

Top Gainers

Top Losers

Shree Ganesh Biotech (India) L Share Price

Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as 'S.P. Commercial Co. Limited' with the Registrar of Companies, West Bengal. The Company got the Certificate of Commencement of Business on September 14, 1982. The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business.

In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Hon'ble High at Calcutta dated February 15, 2010. The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.P. Commercial Co. Limited. Subsequently, Shree Ganesh Bio-Tech (India) Private Limited was dissolved pursuant to the said Scheme of Amalgamation and the name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited. The name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited and a fresh Certificate of Incorporation upon the change of name dated March 7, 2011 was issued by the Registrar of Companies, West Bengal.

The Company is presently engaged in the business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.

Parent organization Indian Private
NSE symbol [-]
Founded 1982
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Shree Ganesh Biotech India Ltd?

Answer Field

Shree Ganesh Biotech India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.61 as on Apr 30 2026 03:30 PM.

What is the Market Cap of Shree Ganesh Biotech India Ltd Share?

Answer Field

The market cap of Shree Ganesh Biotech India Ltd for NSE ₹ 0.00 & for BSE ₹ 24.30 as on Apr 30 2026 03:30 PM.

What is the 52 Week High and Low of Shree Ganesh Biotech India Ltd?

Answer Field

The 52 Week High and Low of Shree Ganesh Biotech India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 0.96 and ₹ 0.54.

What is 1 year return for Shree Ganesh Biotech India Ltd?

Answer Field

The 1 year returns on the stock has been -31.46%.

What is the P/E Ratio of Shree Ganesh Biotech India Ltd Share?

Answer Field

As on Apr 30 2026 03:30 PM the price-to-earnings (PE) ratio for Shree Ganesh Biotech India Ltd share is -61.00.

What is the PB ratio of Shree Ganesh Biotech India Ltd Share?

Answer Field

As on Apr 30 2026 03:30 PM, the price-to-book (PB) ratio for Shree Ganesh Biotech India Ltd share is 1.59.

How to Buy Shree Ganesh Biotech India Ltd Share?

Answer Field

You can trade in Shree Ganesh Biotech India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shree Ganesh Biotech India Ltd Share on Bajaj Broking App?

Answer Field

To buy Shree Ganesh Biotech India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shree Ganesh Biotech India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|